Showing results (671-680 of 784) with videos related to
Sort By:
Pageof 79
Pediatric Dermatology|October 22, 2019
Hamartomas and midline anomalies in association with infantile hemangiomas, PHACE, and LUMBAR syndromesNicole S Stefanko, Olivia M T Davies, Maria Jose Beato, et al.Bioorganic & Medicinal Chemistry Letters|August 24, 2013
Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerasesTimothy J Miles, Alan J Hennessy, Ben Bax, et al.Journal of Medicinal Chemistry|December 11, 2020
Discovery of <b>ANT3310</b>, a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and <i>Acinetobacter baumannii</i>David T Davies, Simon Leiris, Magdalena Zalacain, et al.Bioorganic & Medicinal Chemistry Letters|August 4, 2014
Discovery and in vivo evaluation of alcohol-containing benzothiazoles as potent dual-targeting bacterial DNA supercoiling inhibitorsJames T Palmer, Lorraine C Axford, Stephanie Barker, et al.Anaesthesia|November 3, 2023
Organisation of UK hospitals and anaesthetic departments in the treatment of peri-operative cardiac arrest: an analysis from the 7th National Audit Project (NAP7) local co-ordinator baseline surveyE Kursumovic, J Soar, J P Nolan, et al.Anaesthesia|November 9, 2023
The incidence of potentially serious complications during non-obstetric anaesthetic practice in the United Kingdom: an analysis from the 7th National Audit Project (NAP7) activity surveyA D Kane, T M Cook, R A Armstrong, et al.Anaesthesia|March 1, 2023
Patient characteristics, anaesthetic workload and techniques in the UK: an analysis from the 7th National Audit Project (NAP7) activity surveyA D Kane, J Soar, R A Armstrong, et al.Journal of Medicinal Chemistry|March 29, 2000
Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agentS M Bromidge, S Dabbs, D T Davies, et al.ACS Infectious Diseases|August 14, 2020
ANT2681: SAR Studies Leading to the Identification of a Metallo-β-lactamase Inhibitor with Potential for Clinical Use in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing <i>Enterobacteriaceae</i>David T Davies, Simon Leiris, Nicolas Sprynski, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 27, 2021
Somatic PIK3R1 variation as a cause of vascular malformations and overgrowthCatherine E Cottrell, Nicole R Bender, Michael T Zimmermann, et al.Pageof 79